Mitochondria from distinct tissues are differently affected by 17β-estradiol and tamoxifen

Journal of Steroid Biochemistry and Molecular Biology

Volumn 123, Issue 1-2, 2011, Pages 8-16

  Moreira, Paula I ^a,b   Custódio, José B A ^a,c   Nunes, Elsa ^a,b   Oliveira, Paulo J ^a,d   Moreno, António ^a,d,e   Seia, Raquel ^b   Oliveira, Catarina R ^a,b   Santos, Maria S ^a,d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

17 Estradiol; Brain; Heart; Liver; Mitochondria; Tamoxifen

Indexed keywords

CALCIUM ION; ESTRADIOL; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; MALIC ACID; PLACEBO; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; BIOENERGY; BRAIN MITOCHONDRION; CELL ISOLATION; CONTROLLED STUDY; FEMALE; HEART MITOCHONDRION; HORMONE SUBSTITUTION; HUMAN; LIVER MITOCHONDRION; NONHUMAN; OVARIECTOMY; OXIDATION; PROTEIN PHOSPHORYLATION; RAT; RESPIRATORY CHAIN; UNSPECIFIED SIDE EFFECT;

ANIMALS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LIPID PEROXIDATION; MITOCHONDRIA; MITOCHONDRIA, LIVER; RATS; TAMOXIFEN; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 78650578395     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.09.004     Document Type: Article

References (51)

1. Writing Group for the Womens Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, JAMA 288 (2002) 321-333.
2. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, H. Black, D. Bonds, R. Brunner, R. Brzyski, B. Caan, R. Chlebowski, D. Curb, M. Gass, J. Hays, G. Heiss, S. Hendrix, B.V. Howard, J. Hsia, A. Hubbell, R. Jackson, K.C. Johnson, H. Judd, J.M. Kotchen, L. Kuller, A.Z. LaCroix, D. Lane, R.D. Langer, N. Lasser, C.E. Lewis, J. Manson, K. Margolis, J. Ockene, M.J. OSullivan, L. Phillips, R.L. Prentice, C. Ritenbaugh, J. Robbins, J.E. Rossouw, G. Sarto, M.L. Stefanick, L. Van Horn, J. Wactawski-Wende, R. Wallace, S. Wassertheil-Smoller, Womens Health Initiative Steering Committee, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Womens Health Initiative randomized controlled trial, JAMA 291 (2004) 1701-1712.
3. K. Kwan, C. Ward, J. Marsden, Is there a role for hormone replacement therapy after breast cancer? J. Br. Menopause Soc. 11 (2005) 140-144.
4. D.N. Richardson, The history of Nolvadex, Drug Des. Deliv. 3 (1988) 1-14.
5. Y.C. Lim, L. Li, Z. Desta, Q. Zhao, J.M. Rae, D.A. Flockhart, T.C. Skaar, Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells, J. Pharmacol. Exp. Ther. 318 (2006) 503-512.
6. J.A. Katzenellenbogen, B.W. OMalley, B.S. Katzenellenbogen, Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones, Mol. Endocrinol. 10 (1996) 119-131.
7. M. Sato, M.K. Rippy, H.U. Bryant, Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats, FASEB J. 10 (1996) 905-912. (Pubitemid 26184169)
8. D.P. McDonnell, Selective estrogen receptor modulators (SERMs): a first step in the development of perfect hormone replacement therapy regimen, J. Soc. Gynecol. Invest. 7 (2000) S10-S15.
9. M.R. Duchen, Mitochondria in health and disease; perspectives on a new mitochondrial biology, Mol. Aspects Med. 25 (2004) 365-451.
10. K.B. Wallace, A.A. Starkov, Mitochondrial targets of drug toxicity, Annu. Rev. Pharmacol. Toxicol. 40 (2002) 353-388.
11. J.B. Custdio, A.J. Moreno, K.B. Wallace, Tamoxifen inhibits induction of the mitochondrial permeability transition by Ca2+ and inorganic phosphate, Toxicol. Appl. Pharmacol. 152 (1998) 10-17.
12. J. Zheng, V.D. Ramirez, Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase, J. Steroid. Biochem. Mol. Biol. 68 (1999) 65-75.
13. S.H. Yang, R. Liu, E.J. Perez, Y. Wen, S.M. Stevens Jr., T. Valencia, A.M. Brun- Zinkernagel, L. Prokai, Y. Will, J. Dykens, P. Koulen, J. Simpkins, Mitochondrial localization of estrogen receptor beta, Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4130-4135.
14. P.I. Moreira, J.B. Custodio, C.R. Oliveira, M.S. Santos, Hydroxytamoxifen protects against oxidative stress in brain mitochondria, Biochem. Pharmacol. 68 (2004) 195-204.
15. P.I. Moreira, J.B. Custodio, C.R. Oliveira, M.S. Santos, Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen, Neuropharmacology 48 (2005) 435-447.
16. P.I. Moreira, J.B. Custodio, A. Moreno, C.R. Oliveira, M.S. Santos, Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure, J. Biol. Chem. 281 (2006) 10143-10152.
17. P.I. Moreira, J. Custodio, E. Nunes, A. Moreno, C.R. Oliveira, M.S. Santos, Estradiol affects liver mitochondrial function in ovariectomized and tamoxifen-treated ovariectomized female rats, Toxicol. Appl. Pharmacol. 221 (2007) 102-110.
18. T. Kristin, J. Gertsch, T.E. Bates, B.K. Siesj, Characteristics of the calcium triggered mitochondrial permeability transition in nonsynaptic brain mitochondria: effect of cyclosporin A and ubiquinone 0, J. Neurochem. 74 (2000) 1999-2009.
19. P.I. Moreira, M.S. Santos, A. Moreno, A.C. Rego, C.R. Oliveira, Effect of amyloid beta-peptide on permeability transition pore: a comparative study, J. Neurosci. Res. 69 (2002) 257-267.
20. D.T. Johnson, R.A. Harris, S. French, P.V. Blair, J. You, K.G. Bemis, M. Wang, R.S. Balaban, Tissue heterogeneity of the mammalian mitochondrial proteome, Am. J. Physiol. Cell Physiol. 292 (2007) C689-C697.
21. P. Gazotti, K. Malmstron, M. Crompton, in: E. Carafoli, G. Semenza (Eds.),- Laboratory Manual on Transport and Bioenergetics, Springer Verlag, New York, 1979, pp. 62-69.
22. R.E. Rosenthal, F. Hamud, G. Fiskum, P.J. Varghese, S. Sharpe, Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine, J. Cereb. Blood Flow Metab. 7 (1987) 752-758.
23. P.J. Oliveira, M.S. Santos, K.B. Wallace, Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration, Biochemistry (Moscow) 71 (2006) 194-199.
24. A.G. Gornall, C.J. Bardawill, M.M. David, Determination of serum proteins by means of the biuret reaction, J. Biol. Chem. 177 (1949) 751-766.
25. R.E. Estabrook, Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios, Methods Enzymol. 10 (1967) 41-47.
26. B. Chance, G.R. Williams, Respiratory enzymes in oxidative phosphorylation. VI. The effects of adenosine diphosphate on azide-treated mitochondria, J. Biol. Chem. 221 (1956) 477-489.
27. N. Kamo, M. Muratsugu, R. Hongoh, Y. Kobatake, Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state, J. Membr. Biol. 49 (1979) 105-121.
28. D.E. Wingrove, T.E. Gunter, Kinetics of mitochondrial calcium transport. II. A kinetic description of the sodium-dependent calcium efflux mechanism of liver mitochondria and inhibition by ruthenium red and by tetraphenylphosphonium, J. Biol. Chem. 261 (1986) 15166-15171.
29. M. Muratsugu, N. Kamo, K. Kurihara, Y. Kobatake, Selective electrode for dibenzyl dimethyl ammonium cation as indicator of the membrane potential in biological systems, Biochim. Biophys. Acta 464 (1977) 613-619.
30. S. Rajdev, I.J. Reynolds, Calcium green-5N, a novel fluorescent probe for monitoring high intracellular free Ca2+ concentrations associated with glutamate excitotoxicity in cultured rat brain neurons, Neurosci. Lett. 162 (1993) 149-152.
31. P.J. Hissin, R. Hilf, A fluorometric method for determination of oxidized and reduced glutathione in tissues, Anal Biochem. 74 (1976) 214-226.
32. M.S. Santos, D.L. Santos, C.M. Palmeira, R. Seic a, A.J. Moreno, C.R. Oliveira, Brain and liver mitochondria isolated from diabetic Goto-Kakizaki ratsshowdifferent susceptibility to induced oxidative stress, Diabetes Metab. Res. Rev. 17 (2001) 223-230.
33. G. Barja, Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity, J. Bioenerg. Biomembr. 31 (1999) 347-366.
34. Writing Group for the PEPI Trial, Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial, JAMA 273 (1995) 199-208.
35. I. Cicha, Y. Suzuki, N. Tateishi, N. Maeda, Enhancement of red blood cell aggregation by plasma triglycerides, Clin. Hemorheol. Microcirc. 24 (2001) 247-255.
36. N. Maeda, I. Cicha, N. Tateishi, Y. Suzuki, Triglyceride in plasma: prospective effects on microcirculatory functions, Clin. Hemorheol. Microcirc. 34 (2006) 341-346.
37. J.M. Fromson, S. Pearson, S. Bramah, The metabolism of tamoxifen (I.C.I. 46, 474). I. In laboratory animals, Xenobiotica 3 (1973) 693-709.
38. C.L. Liu, J.K. Huang, S.P. Cheng, Y.C. Chang, J.J. Lee, T.P. Liu, Fatty liver and transaminase changes with adjuvant tamoxifen therapy, Anticancer Drugs 17 (2006) 709-713.
39. J.F. McElroy, G.N. Wade, Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats, Physiol. Behav. 39 (1987) 361-365.
40. G.N. Wade, J.E. Schneider, Metabolic fuels and reproduction in female mammals, Neurosci. Biobehav. Rev. 16 (1992) 235-272.
41. I.V. van Seumeren, Weight gain and hormone replacement therapy: are womens fears justified? Maturitas 34 (2000) S3-S8.
42. G.N. Wade, H.W. Heller, Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats, Am. J. Physiol. 264 (1993) R1219-R1223.
43. M. Lopez, C.J. Lelliott, S. Tovar, W. Kimber, R. Gallego, S. Virtue, M. Blount, M.J. Vazquez, N. Finer, T.J. Powles, S. ORahilly, A.K. Saha, C. Dieguez, A.J. Vidal-Puig, Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl- CoA, Diabetes 55 (2006) 1327-1336.
44. D.R. Green, G. Kroemer, The pathophysiology of mitochondrial cell death, Science 305 (2004) 626-629.
45. J. Nilsen, R.W. Irwin, T.K. Gallaher, R.D. Brinton, Estradiol in vivo regulation of brain mitochondrial proteome, J. Neurosci. 27 (2007) 14069-14077.
46. Y.H. Huang, Q.H. Zhang, Genistein reduced the neural apoptosis in the brain of ovariectomised rats by modulating mitochondrial oxidative stress, Br. J. Nutr. 28 (2010) 1-7.
47. A. Razmara, L. Sunday, C. Stirone, X. Wang, D. Krause, S. Duckles, V. Procaccio, Mitochondrial effects of estrogen are mediated by estrogen receptor alpha in brain endothelial cells, J. Pharmacol. Exp. Ther. 325 (2008) 782-790.
48. A.M. Billeci, M. Paciaroni, V. Caso, G. Agnelli, Hormone replacement therapy and stroke, Curr. Vasc. Pharmacol. 6 (2008) 112-123.
49. R. Morkuniene, O. Arandarcikaite, V. Borutaite, Estradiol prevents release of cytochrome c from mitochondria and inhibits ischemia-induced apoptosis in perfused heart, Exp. Gerontol. 41 (2006) 704-708.
50. C.M. Liou, A.L. Yang, C.H. Kuo, H. Tin, C.Y. Huang, S.D. Lee, Effects 17betaestradiol on cardiac apoptosis in ovariectomized rats, Cell Biochem. Funct. 28 (2010) 521-528.
51. S. Konyalioglu, G. Durmaz, A. Yalcin, The potential antioxidant effect of raloxifene treatment: a study on heart, liver and brain cortex of ovariectomized female rats, Cell Biochem. Funct. 25 (2007) 259-266.